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Interleukin-17 (IL-17) has been shown to participate in the development of Lyme arthritis in experimental mice. For example, neutralization of IL-17 with antibodies inhibits induction of arthritis in Borrelia-primed and -infected C57BL/6 wild-type mice. We hypothesized that mice lacking IL-17 would fail to develop Borrelia-induced arthritis. IL-17-deficient and wild-type C57BL/6 mice were primed with 
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heat-inactivated Borrelia and then infected with viable spirochetes 3 weeks later. No swelling or major histopathological changes of the hind paws were detected in IL-17-deficient or wild-type mice that were primed with Borrelia or infected with viable spirochetes. By contrast, IL-17-deficient and wild-type mice that were primed and subsequently infected with heterologous Borrelia developed severe swelling and histopathological changes of the hind paws. In addition, Borrelia-primed and -infected IL-17-deficient mice exhibited elevated gamma-interferon (IFN-γ) levels in sera and increased frequencies of IFN-γ-expressing lymphocytes in popliteal lymph nodes compared to Borrelia-primed and -infected wild-type mice. These results demonstrate that IL-17 is not required for development of severe pathology in response to infection with Borrelia burgdorferi, but may contribute to disease through an interaction with IFN-γ. Keywords: Lyme arthritis, Borrelia burgdorferi, interleukin-17, gamma-interferon, T cells Introduction Lyme borreliosis, caused by Borrelia burgdorferi sensu lato spirochetes, is the most common tick-borne human disease reported in the USA and Europe. Arthritis is one of the most frequent late disease manifestations of Lyme borreliosis, affecting ∼60% of infected, but untreated, individuals in North America (Steere, Schoen and Taylor 1987). Despite antimicrobial treatment, 10% of these arthritic patients develop chronic joint inflammation (Steere, Schoen and Taylor 1987), resulting in permanent cartilage and bone damage, causing pain and affecting mobility. The immune mechanisms responsible for the development of Lyme arthritis are partially understood. We have provided evidence that interleukin-17 (IL-17), a pro-inflammatory cytokine produced by T helper (Th) 17 cells, is involved in the development of Borrelia-induced arthritis in a mouse model of disease (Burchill et al.2003; Nardelli et al.2004, 2008; Kotloski et al. 2008; Kuo et al.2011; Hansen et al.2013). IL-17 has also been shown to participate in the development of rheumatoid arthritis, collagen-induced arthritis and other chronic inflammatory diseases (Chabaud et al.2000; Lubberts et al.2004; Agarwal, Misra and Aggarwal 2008; Pinto et al.2010; Isailovic et al.2015; Owaga et al.2015). Importantly, Infante-Duarte et al. (2000) showed that IL-17 was produced by synovial T cells of human patients with Lyme arthritis in response to borrelial antigens. Subsequently, Codolo et al. (2008, 2013) showed that IL-17 was secreted by synovial T cells of human patients with Lyme arthritis after stimulation with neutrophil-activating protein A of B. burgdorferi. These findings, along with our previous work describing the involvement of Th17-associated cytokines (Burchill et al.2003; Nardelli et al.2004, 2008; Kotloski et al.2008; Kuo et al.2011; Hansen et al.2013), suggest that IL-17 is involved in the pathogenesis of arthritis following infection with B. burgdorferi. 
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We previously used a model with Borrelia-primed and -infected wild-type and gamma interferon (IFN-γ)-deficient C57BL/6 mice for inducing arthritis (Burchill et al.2003; Christopherson et al.2003; Nardelli et al.2004, 2005, 2006, 2008; Amlong et al.2006; Kotloski et al.2008; Kuo et al.2011; Hansen et al.2013) that is driven by T cells (Lim et al.1995a,b), as occurs in humans with later-stage Lyme disease (Chen et al.1999; Pianta et al.2015). We showed that mice primed with heat-inactivated Borrelia and subsequently infected with a live, heterologous borrelial strain developed severe, destructive, IL-17-dependent arthritis in the absence of IFN-γ (Burchill et al.2003; Nardelli et al.2004). In addition, we showed (Nardelli et al.2006, 2008; Kotloski et al.2008; Kuo et al.2011) that IL-17-dependent arthritis of moderate severity also developed in Borrelia-primed and -infected wild-type mice. Infiltration of lymphocytes was observed in the synovial and subsynovial tissues of Borrelia-primed and -infected mice compared to control groups (Kotloski et al.2008). Furthermore, sera and lymph node cell cultures from arthritic Borrelia-primed and -infected mice showed increased levels of IL-17 compared to control groups (Amlong et al.2006; Kotloski et al.2008; Kuo et al.2011). Neutralization of IL-17 inhibited the development of arthritis in these mice (Burchill et al.2003; Nardelli et al.2004, 2005, 2008). This demonstrates that IL-17 and, possibly, T lymphocytes, such as Th17 cells, play a role in the induction of arthritis in the Borrelia-primed and -infected murine model of Lyme arthritis. Although there is considerable evidence that IL-17 is associated with the development of Lyme arthritis (Codolo et al.2008, 2013; D'Elios, Codolo and de Bernard 2009; Oosting et al.2011), in addition to our work with Borrelia-primed and -infected mice (Burchill et al.2003; Christopherson et al.2003; Nardelli et al.2004, 2005, 2006, 2008; Amlong et al.2006; Kotloski et al.2008; Kuo et al.2011; Hansen et al.2013), we questioned whether IL-17 is required for the induction of Lyme arthritis. In this study, we hypothesized that arthritis would not develop in IL-17-deficient Borrelia-primed and -infected C57BL/6 mice. However, IL-17-deficient Borrelia-primed and -infected C57BL/6 mice developed arthritis, indicating that IL-17 is not solely responsible for the pathogenesis of arthritis in this animal model. Materials and Methods Mice Six to eight week-old male IL-17-deficient C57BL/6 mice were provided by Dr Bruce Klein and Dr Marcel Wuethrich (University of Wisconsin School of Medicine and Public 
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Health) with permission from Dr Yoichiro Iwakura (University of Tokyo's Institute of Medical Science). Wild-type mice of the same age were purchased from Jackson Laboratory (West Sacramento, CA, USA). All mice were kept at the animal facility located at the University of Wisconsin School of Medicine and Public Health. Mice were maintained under a pathogen-free condition at 21°C with food and acidified water provided ad libitum during daily cycles of 12 h of light and darkness. Experimental protocols were approved by the Animal Care and Use Committee of the University of Wisconsin School of Medicine and Public Health. Organisms and preparation Low-passage-number (<10) virulent Borrelia bissettii and B. burgdorferi isolate 297 were cultured in modified Barbour-Stoenner-Kelly (BSK) medium until reaching a concentration of 107 spirochetes/ml. Samples of 500 μl were dispensed into 1.5 ml screw 
cap tubes (Sarstedt; Newton, NC, USA) containing 500 μl of BSK medium with 10% glycerol (Sigma-Aldrich; St. Louis, MO, USA). Spirochetes were stored at –70°C until used. Priming of mice A frozen suspension of B. bissettii was thawed, heated in a water bath at 56°C for 30 min and examined by dark field microscopy. No motility was detected. In addition, an aliquot of the heat-inactivated suspension of B. bissettii failed to grow in fresh BSK medium after 7 days of incubation. Heat-inactivated B. bissettii organisms were then washed three times by centrifugation at 10 000× g with ice-cold phosphate-buffered saline (PBS, pH 7.4) that was filter-sterilized with a 0.2-μm-pore-size filter (Gelman Sciences; Ann Arbor, MI, USA). Subsequently, washed B. bissettii organisms were resuspended in PBS and mixed with a volume of 1% aluminum hydroxide (Reheis; Berkeley Heights, NJ, USA) to yield a concentration of 2 × 106 spirochetes/ml. Mice were then anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the sural region near the popliteal lymph node of the hind limb with 0.10 ml of the vaccine using a 23-gauge needle. Infection of mice A frozen suspension of B. burgdorferi isolate 297 was thawed and mixed with 4 ml of fresh BSK medium. The spirochetal culture was incubated at 32°C until reaching a concentration of 2 × 107 viable spirochetes/ml. Twenty-one days after priming of mice with heat-inactivated B. bissettii, mice were anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the right hind paw with 1 × 106 (50 μl) B. 
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burgdorferi isolate 297 organisms with a 27-gauge needle. The heterologous infection with B. burgdorferi isolate 297 induces arthritis and is not affected by the presence of priming-induced anti-B. bissettii antibodies. We have shown that infection with viable heterologous Borrelia organisms can induce arthritis (Lim et al. 1995a,b). If priming and infection are conducted with the same isolate of B. burgdorferi, arthritis will not develop if specific borreliacidal antibodies are present (Croke et al.2000). Controls also included mice injected with BSK medium. Assessment of swelling Swelling of the right hind paws of mice was measured with a digital caliper (Mitutoyo American Corporation; Aurora, IL, USA) with a sensitivity of 0.01 mm prior to infection with B. burgdorferi isolate 297 and every other day for 8 days. Mice were anesthetized with isoflurane contained in a nose-and-mouth cup, and the width and thickness of each hind paw at the tibiotarsal joint were measured. Caliper values within a group were averaged to obtain the mean caliper value for comparison of the degree of swelling. Tissue preparation for histological examination Eight days after infection, mice were euthanized with isoflurane, and the right hind paw of each mouse was amputated at mid-femur. Paws were first placed in decalcifying solution (Lerner Laboratories; Pittsburgh, PA, USA) for 24 h, and then stored in 10% neutral buffered formalin solution for 48 h (Sigma-Aldrich). Paws were then placed in tissue-embedding cassettes (Fisher Scientific; Hanover Park, IL, USA), embedded in paraffin and cut into three to five 6-μm-thick sections. Each section of the hind paws was placed onto a glass slide and stained with hematoxylin and eosin. Sections were cryptically coded, and a board-certified pathologist (T. F. Warner) performed fully blinded histopathological examinations of the tissues. The following ratings were used: 0, no histopathological changes; 1, mild infiltration of polymorphonuclear cells; 2, hyperplasia or villus formation with moderate infiltration of polymorphonuclear cells and lymphocytes; 3, severe hyperplasia with villus formation and infiltration of polymorphonuclear cells and lymphocytes. Enzyme-linked immunosorbent assay Serum from each mouse was collected at day 8 after infection. IFN-γ and IL-17 levels in each serum sample were measured with a Mouse Gamma-Interferon ELISA Ready-Set-
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Go! Kit and Mouse Interleukin-17 ELISA Ready-Set-Go! Kit (eBioscience; San Diego, CA, USA), respectively. The change in optical density measured in 450 and 570 nm was obtained for each sample. A standard curve was generated, and data were expressed in picograms of IFN-γ and IL-17 per milliliter of serum. Flow cytometry Spleens and popliteal lymph nodes of mice were obtained 8 days after infection. Single-cell suspensions of lymph node cells and splenocytes were prepared by passing cells through a sterile nylon mesh screen (Fisher; Hanover Park, IL, USA) into cold filter-sterilized PBS in centrifuge tubes on ice. Red blood cells were lysed and discarded from suspensions of splenocytes. Total numbers of viable cells were determined using trypan blue exclusion and enumeration with a hemocytometer. The suspensions were diluted to 1 × 107 cells/ml. A total of 5 × 105 cells from each sample were then transferred to a sterile tissue culture treated 96-well plate (Corning; Corning, NY, USA). Cells were first incubated for 30 min on ice with Fixable Viability Dye eFluor 780 (eBiosciences) to differentiate viable from non-viable cells. Then, cells were incubated in the dark at 4°C for 30 min during surface staining with fluorescein isothiocyanate-conjugated rat anti-mouse CD4 antibody and Pacific Blue-conjugated rat anti-mouse CD8 antibody (BD Biosciences; San Jose, CA, USA). The antibody-to-cell ratio was determined to maximize recognition of CD4+ or CD8+ cells. Isotype controls were also included. After incubation, cells were permeabilized, and stained intracellularly with allophycocyanin-conjugated rat anti-mouse IFN-γ antibody and phycoerythrin-conjugated rat anti-mouse IL-17 antibody (BD Biosciences) in the dark at 4°C for 30 min. Cells were then fixed with 5% formalin, and data were acquired using a BD LSRFortessa cell analyzer (BD Biosciences). Events were gated to include viable lymphocytes that were CD4+ or CD8+ and evaluated for expressing IFN-γ or IL-17. The percentage of these specific cells is in relation to the entire lymphoid organ population. A total of 30 000 gated events were collected and analyzed with FlowJo single cell analysis software (Tree Star; Ashland, OR, USA). Statistics Swelling of the hind paws among different groups of Borrelia-primed and -infected mice and concentrations of IL-17 were evaluated by Fisher's protected least-significant-difference test and one-way analysis of variance (ANOVA) through R Commander. The alpha level was set at 0.05. Data are presented as the average with two standard errors of the mean. 
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Results Hind paw swelling in IL-17-deficient C57BL/6 mice The purpose of this study was to determine if Borrelia-primed and -infected mice developed hind paw swelling in the absence of IL-17. Wild-type and IL-17-deficient mice were divided randomly into four groups: non-primed and uninfected but injected with BSK medium, Borrelia-primed but uninfected, non-primed but Borrelia-infected and Borrelia-primed and -infected. There were four mice in each group, and the study was replicated twice, using a total of 12 mice per group. Right hind paws of mice in each group were measured every other day for swelling. Mice were then euthanized on day 8 after infection, and their hind paws, sera, spleens and popliteal lymph nodes were harvested. No swelling of the hind paws was detected in IL-17-deficient or wild-type C57BL/6 mice that were solely infected with Borrelia burgdorferi strain 297 or solely primed with B. bissettii (Fig. 1). By contrast, Borrelia-primed and -infected IL-17-deficient mice developed significantly (P < 0.05) greater hind paw swelling between days 4 through 8 of infection than non-primed and uninfected, Borrelia-primed but uninfected or non-primed but Borrelia-infected mice of either genotype. However, the degree of swelling of Borrelia-primed and -infected wild-type mice between days 0 and 8 was notably greater than the overall swelling of Borrelia-primed and -infected IL-17-deficient mice. Similar results were obtained when this study was repeated twice. Figure 1. 
 Development of hind paw swelling of IL-17-deficient and wild-type C57BL/6 mice that are non-primed and uninfected, Borrelia-primed but uninfected, non-primed but Borrelia-infected and Borrelia-primed and -infected. Error bars represent the mean hind paw swelling ± two standard errors. Asterisks denote 
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a significant (P ≤ 0.05) difference in swelling among groups of mice. Data were obtained from three experiments. Twelve mice were used in total per group. Histopathological confirmation of arthritis Tibiotarsal joints of Borrelia-primed and -infected IL-17-deficient and wild-type mice exhibited similar histopathological changes in the synovium and perisynovium (Table 1). Specifically, there was little difference between IL-17-deficient and wild-type mice in scores for synovial hyperplasia and villus formation, and infiltration of polymorphonuclear cells and lymphocytes into the perisynovium. By contrast, the histopathological changes in non-primed but Borrelia-infected IL-17-deficient mice were generally greater than the changes observed in non-primed but Borrelia-infected wild-type mice. Of these four groups of mice, non-primed but Borrelia-infected wild-type mice had the least pathology in the synovium. In the perisynovium, considerable lymphocytic infiltration occurred in Borrelia-primed and -infected IL-17-deficient and wild-type mice compared to non-primed but Borrelia-infected IL-17-deficient and wild-type mice. In addition, infiltration of neutrophils was significantly less in Borrelia-primed and -infected IL-17-deficient and wild-type mice compared to non-primed but Borrelia-infected IL-17-deficient and wild-type mice. Table 1. Histopathological changes observed in the tibiotarsal joints of IL-17-deficient and wild-type C57BL/6 mice that are non-primed and uninfected, Borrelia-primed but uninfected, non-primed but Borrelia-infected and Borrelia-primed and -infected. Data were obtained from three experiments.   Synovium  Perisynovium      Villi  Polymorphonuclear  Lymphocyte    Hyperplasia  formation  cell infiltrations  infiltrations  Group, with treatment and phenotype of mice  Score  Score  Score  Score  Non-primed and uninfected IL-17-deficient  0.00a  0.00a  0.00a  0.00a  Non-primed and uninfected wild-type  0.00a  0.00a  0.00a  0.00a  Primed but uninfected IL-17-deficient  0.00a  0.00a  0.00a  0.00a  Primed but uninfected wild-type  0.00a  0.00a  0.00a  0.00a  Non-primed but infected IL-17-deficient  1.15b  0.15a  2.13c  1.91c  Non-primed but infected wild-type  0.16a  0.08a  1.91c  0.83b  Primed and infected IL-17-deficient  1.25b  0.50b  0.83b  2.42d  Primed and infected wild-type  1.58b  0.75b  0.83b  2.66d  a–dMean histopathological scores with different superscript in each category indicate significant difference from Fisher's protected least-significant-difference test, with alpha-value of 0.05 when comparing experimental groups with one another. IFN-γ and IL-17 in sera and popliteal lymph node cells 
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We measured levels of IFN-γ and IL-17 in sera to determine whether production of IFN-γ and/or IL-17 was associated with the induction of arthritis in Borrelia-primed and -infected mice. Sera obtained from Borrelia-primed and -infected IL-17-deficient and wild-type mice had significantly greater levels of IFN-γ than sera from non-primed and uninfected, Borrelia-primed but uninfected and non-primed but Borrelia-infected IL-17-deficient and wild-type mice (Fig. 2A). However, Borrelia-primed and -infected IL-17-deficient mice had significantly greater levels of IFN-γ in sera compared to Borrelia-primed and -infected wild-type mice. As expected, no IL-17 was detected in sera of IL-17-deficient mice (Fig. 2B). Higher levels of IL-17 were detected in sera from arthritic Borrelia-primed and -infected wild-type mice compared to non-primed and uninfected, Borrelia-primed but uninfected and non-primed but Borrelia-infected wild-type mice, all of which were non-arthritic. Figure 2. 
 The concentration (picograms per milliliter) of gamma-interferon (A) and IL-17 (B) in sera obtained from IL-17-deficient and wild-type C57BL/6 mice that are non-primed and uninfected, Borrelia-primed but uninfected, non-primed but Borrelia-infected and Borrelia-primed and -infected. Error bars 
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represent the mean picogram concentration in sera ± two standard errors. Asterisks denote a significant (P ≤ 0.05) difference compared to all other mice with or without the same genotype, and with or without same experimental treatment. Data were obtained from three experiments. Flow cytometry was conducted to determine whether splenocytes and popliteal lymph node cells, specifically CD4+ and CD8+ lymphocytes, expressed IFN-γ and IL-17. The percentage of CD4+ and CD8+ splenocytes expressing IFN-γ was not statistically different among non-primed and uninfected, Borrelia-primed but not infected, non-primed but Borrelia-infected and Borrelia-primed and -infected IL-17-deficient and wild-type mice (Fig. 3A). IL-17-expressing CD4+ and CD8+ lymphocytes in the spleen were not detected in IL-17-deficient mice (Fig. 3B). The percentage of IL-17-expressing CD4+ and CD8+ splenocytes was also not significantly different among all groups of wild-type mice. Figure 3. 
 The percentage of splenocytes expressing IFN-γ (A) and IL-17 (B), and popliteal lymph node cells expressing IFN-γ (C) and IL-17 (D) from IL-17-deficient and wild-type C57BL/6 mice that are non-primed and uninfected, Borrelia-primed but uninfected, non-primed but Borrelia-infected and Borrelia-primed and -infected. Asterisks denote a significant (P ≤ 0.05) difference in percentage of cells compared to all other mice with or without the same genotype, and with or without same experimental treatment. Error bars represent the mean percentage ± two standard errors. Data were obtained from three experiments. However, a significant percentage of IFN-γ-expressing CD4+ and CD8+ lymphocytes was detected among popliteal lymph node cells of Borrelia-primed and -infected IL-17-deficient mice and other groups of IL-17-deficient mice compared to Borrelia-primed and -infected wild-type mice (Fig. 3C). The percentage of IFN-γ-expressing CD4+ and CD8+ popliteal lymph node cells in Borrelia-primed and -infected wild-type mice was similar to non-primed and uninfected, Borrelia-primed but uninfected and non-primed but Borrelia-infected IL-17-deficient and wild-type mice. In addition, a significant percentage of IL-17-expressing CD4+ and CD8+ popliteal lymph node cells was detected in Borrelia-primed and 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the 
link in the citation at the bottom of the page. 
Pathogens and disease, Vol. 74, No. 7 (October 1, 2016): pg. ftw077. DOI. This article is © Oxford University Press and permission has been 
granted for this version to appear in e-Publications@Marquette. Oxford University Press does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Oxford University Press. 
11 
 
-infected wild-type mice (Fig. 3D) compared to other groups of wild-type mice. No IL-17 expression was detected among popliteal lymph node cells from IL-17-deficient mice. Discussion IL-17 has been implicated as a contributor to Lyme arthritis (Infante-Duarte et al.2000; Knauer et al.2007; Codolo et al.2008, 2013; D'Elios, Codolo and de Bernard 2009; Oosting et al.2011). We previously showed that when Borrelia-primed C57BL/6 wild-type mice are infected with Borrelia burgdorferi, arthritis develops in the tibiotarsal joints (Nardelli et al.2006, 2008; Kotloski et al.2008; Kuo et al.2011). The arthritis can be destructive, reducing the mobility of Borrelia-primed and -infected hamsters (Lim et al.1995a,b; Croke et al.2000) or IFN-γ-deficient mice (Burchill et al.2003; Christopherson et al.2003; Nardelli et al.2004, 2005, 2006; Amlong et al.2006). Blocking IL-17 in vivo ameliorates the pathology of the tibiotarsal joints in Borrelia-primed and -infected wild-type (Nardelli et al.2008) and IFN-γ-deficient (Burchill et al.2003; Nardelli et al.2004) mice. In support of the arthritogenic ability of IL-17, Infante-Duarte et al. (2000) and others (Codolo et al.2008, 2013; D'Elios, Codolo and de Bernard 2009) showed that synovial cells of human Lyme arthritis patients produce IL-17. In addition, IL-17 levels are increased in cerebrospinal fluid of patients with Lyme neuroborreliosis (Henningsson et al.2011) and patients with prolonged Lyme disease (Oosting et al.2011). Collectively, these results suggest that IL-17 plays a major role in the induction of Lyme-related pathology, including arthritis. However, no direct evidence illustrates that IL-17 is absolutely necessary for the induction and progression of Lyme arthritis. Here, we report that IL-17 is not essential for the development of arthritis. Our results with wild-type C57BL/6 mice in this study are consistent with our previous findings (Nardelli et al.2006, 2008), showing that wild-type C57BL/6 mice infected with viable spirochetes after priming with heat-inactivated Borrelia develop arthritis and respond to infection in the perisynovial tissue with an infiltration of predominantly lymphocytes. Significantly elevated IL-17 levels (161 ± 17.5 pg/ml) in sera of Borrelia-primed and -infected wild-type C57BL/6 mice were also observed compared to the other experimental groups, indicating that IL-17 may contribute to the induction of arthritis. In addition, a significant percentage of IL-17-expressing CD4+ and CD8+ lymphocytes were detected in popliteal lymph nodes of these mice. Since IL-17-producing CD4+ and CD8+ cells have been shown to enhance autoimmune encephalomyelitis (Huber et al.2013), psoriatic arthritis (Menon et al.2014) and other inflammatory diseases, these IL-17-producing cells may be responsible for the Borrelia-induced arthritis seen in wild-type C57BL/6 mice primed and 
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infected with a heterologous strain. However, contrary to our hypothesis, arthritis is also developed in Borrelia-primed IL-17-deficient mice upon infection. Hind paw swelling and infiltration of predominantly lymphocytes were detected in the perisynovial tissue. As expected, no IL-17 was detected in their sera or in cells obtained from the spleen or popliteal lymph nodes. These results suggest that IL-17-producing immune cells are not required for the induction of arthritis in Borrelia-primed and -infected mice. What could contribute to the Borrelia-induced arthritis observed in IL-17-deficient and wild-type mice? Cytokines often are influenced by a number of immune modulating agents. Doodes et al. (2008) showed elevated levels of IFN-γ in supernatants of harvested splenocytes from IL-17-deficient mice with proteoglycan-induced arthritis, suggesting a Th1-mediated response in lack of IL-17. We therefore suspect that Borrelia-primed IL-17-deficient and wild-type mice have other functioning immune cells, including IFN-γ-producing CD4+ and CD8+ cells, that can induce arthritis. We show in this study that when Borrelia-primed mice are infected with viable spirochetes in the presence or absence of IL-17, a notable IFN-γ response is induced. The level of IFN-γ in serum of IL-17-deficient Borrelia-primed and -infected C57BL/6 mice (134 ± 15.0 pg/ml) is elevated compared to the level detected in Borrelia-primed and -infected wild-type mice (81 ± 12.0 pg/ml). IFN-
γ levels were 60 pg/ml or less in IL-17-deficient and wild-type mice that were non-primed and uninfected, Borrelia-primed but uninfected and non-primed but Borrelia-infected. In addition, the percentage of IFN-γ-expressing CD4+ and CD8+ lymphocytes was greater in the popliteal lymph nodes that drain the arthritic site of Borrelia-primed and -infected IL-17-deficient mice compared to the other groups. No difference in expression of IFN-γ among the groups was detected with splenocytes. Failure to detect IFN-γ in the splenocytes may be the result of a localized immune response with confined processing of Borrelia to the popliteal lymph node cells of the hind paws, the initial site of infection. Our data suggest a role for IFN-γ in the induction of arthritis in wild-type mice and mice deficient in IL-17. IFN-γ has long been known as an inflammatory agent in later-stage Lyme arthritis (Yssel et al.1991; Dong, Edelstein and Glickstein 1997; Yin et al.1997; Gross, Steere and Huber 1998; Strle et al.2012). Production of IFN-γ from predominately CD4+ Th1 (Yssel et al.1991; Yin et al.1997; Gross, Steere and Huber 1998; Strle et al.2012) and, to a lesser extent, CD8+ cytotoxic T cells (Dong, Edelstein and Glickstein 1997) has been associated with increased inflammation and severity of Borrelia-induced arthritis (Yssel et al.1991; Dong, Edelstein and Glickstein 1997; Yin et al.1997; Gross, Steere and Huber 1998; Strle et al.2012). In this study, IFN-γ levels in sera were significantly increased when comparing arthritic Borrelia-primed and -infected IL-17-deficient and wild-type mice to non-primed and uninfected, primed but uninfected and non-primed but infected mice with 
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no major arthritic symptoms. However, we also showed previously that Borrelia-primed IFN-γ-deficient mice develop severe arthritis after infection with B. burgdorferi (Burchill et al.2003; Christopherson et al.2003; Nardelli et al.2004; Amlong et al.2006). The arthritis observed in these IFN-γ-deficient mice was dependent on IL-17. In support, treatment of Borrelia-primed and -infected IFN-γ-deficient mice with antibodies directly targeting IL-17 abrogated the development of arthritis (Burchill et al.2003; Nardelli et al.2004). It is plausible that Borrelia-primed mice depleted of IFN-γ compensate with an IL-17-mediated inflammatory response to B. burgdorferi. With this same reasoning, Borrelia-primed and -infected IL-17-deficient mice may promote pro-inflammatory Th1 and IFN-γ responses upon infection. In mice with proteoglycan-induced arthritis, overproduction of IFN-γ compensates for the absence of IL-17 (Doodes et al.2008) and vice versa (Doodes et al.2010). Shifting production to IL-17 or IFN-γ in these respective animal models of cytokine deficiency could account for the development of arthritis. In this study, we show that mild histopathological changes occur in the hind paws of IL-17-deficient Borrelia-infected mice in the absence of priming. We also show that minimal histopathological changes develop in non-primed but Borrelia-infected wild-type C57BL/6 mice, which is consistent with our previous findings (Kotloski et al.2008). These two groups respond to infection with a predominant infiltration of neutrophils and mild to moderate infiltration of lymphocytes, respectively in the ankle joint. In contrast, IL-17-deficient or wild-type mice infected with viable spirochetes after priming with heat-inactivated Borrelia respond to infection by infiltration of predominantly lymphocytes. The difference in infiltration of predominantly neutrophils or lymphocytes may explain the disparity in the severity of arthritis that develops between Borrelia-primed and non-primed IL-17-deficient and wild-type mice. We speculate that borrelial proteins such as neutrophil-activating protein A (Codolo et al.2008, 2013) stimulate the innate immune system for influx of neutrophils in non-primed but Borrelia-infected IL-17-deficient and wild-type mice. The infection may be better controlled, and development of arthritis is less severe. In contrast, other borrelial antigens encountered during infection may stimulate the acquired immune response induced by Borrelia priming with an influx of lymphocytes that augment the severity of arthritis. In support of this hypothesis, CD4+ T lymphocytes have been shown to be responsible for development of arthritis in Borrelia-primed and -infected hamsters (Lim et al.1995a,b). This likely explains why the Borrelia-priming and -infection model exhibits arthritis in an otherwise arthritis-resistant murine strain. The involvement of T cells is shown in this study by the increased Th1 response in the serum and tissues of these mice, which is exacerbated in the absence of IL-17. However, both the innate and acquired immune responses are involved in response to infection with B. burgdorferi. How 
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the innate and acquired immune responses collaborate to induce arthritis needs to be studied further to provide a more complete picture of the mechanism of Lyme arthritis. In conclusion, we show that IL-17-deficient Borrelia-primed and -infected mice develop arthritis, contrary to our initial hypothesis. A strong IFN-γ response was observed in these mice, supporting the known function of this cytokine in the development of disease. Our current findings, coupled with previous studies showing that murine Lyme arthritis can develop in the absence of IFN-γ in multiple animal models (Burchill et al.2003; Christopherson et al.2003; Nardelli et al.2004), further support the concept that a series of complex cytokine interactions are involved in the development of Lyme arthritis. Despite our current findings, evidence suggests that IL-17 likely contributes to the development of Lyme arthritis in some animal models (Burchill et al.2003; Nardelli et al.2004, 2008, 2010; Kotloski et al.2008; Kuo et al.2011; Hansen et al.2013) and may contribute to disease in some human patients (Infante-Duarte et al.2000; Knauer et al.2007; Codolo et al.2008, 2013; D'Elios, Codolo and de Bernard 2009; Oosting et al.2011). Further examination of the role IL-17 and IFN-γ play in this complex immune response may yield novel therapeutic strategies to treat Lyme arthritis. We thank dean A. Jobe and Steve M. Callister at Gundersen Lutheran Medical Center (La Crosse, WI, USA) for providing spirochetal cultures and Barbour-Stoenner-Kelly medium. We also thank Beth A. Gray from the University of Wisconsin-Madison for preparing tissues for histological examinations, and David J. Gasper and Brandon T. Neldner for assistance in flow cytometry. Funding 
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